- Previous Close
2.9600 - Open
2.8600 - Bid 2.7000 x 1000
- Ask 2.9900 x 1000
- Day's Range
2.7500 - 3.0000 - 52 Week Range
2.6400 - 4.6000 - Volume
43,269 - Avg. Volume
14,582 - Market Cap (intraday)
19.26M - Beta (5Y Monthly) 0.42
- PE Ratio (TTM)
4.92 - EPS (TTM)
0.6100 - Earnings Date May 12, 2025 - May 16, 2025
- Forward Dividend & Yield --
- Ex-Dividend Date Jun 28, 2007
- 1y Target Est
4.85
American Shared Hospital Services provides stereotactic radiosurgery and advanced radiation therapy equipment. It operates in two segments, Medical Equipment Leasing, and Retail. The company offers radiosurgery equipment for the Gamma Knife stereotactic radiosurgery, a non-invasive procedure to treat malignant and benign brain tumors, and arteriovenous malformations, as well as for trigeminal neuralgia. It also provides financing services for Leksell Gamma Knife units; and leases medical equipment. In addition, the company offers proton beam radiation therapy services in Orlando, Florida and Long Beach, California, as well as offers planning, installation, reimbursement, and marketing support services to its customers. The company markets its solutions to cancer treatment centers, hospitals, and cancer networks worldwide. American Shared Hospital Services was founded in 1980 and is based in San Francisco, California.
ashs.com31
Full Time Employees
December 31
Fiscal Year Ends
Sector
Industry
Recent News: AMS
View MorePerformance Overview: AMS
Trailing total returns as of 4/4/2025, which may include dividends or other distributions. Benchmark is S&P 500 (^GSPC) .
YTD Return
1-Year Return
3-Year Return
5-Year Return
Compare To: AMS
Select to analyze similar companies using key performance metrics; select up to 4 stocks.
Statistics: AMS
View MoreValuation Measures
Market Cap
19.26M
Enterprise Value
29.59M
Trailing P/E
4.92
Forward P/E
10.00
PEG Ratio (5yr expected)
--
Price/Sales (ttm)
0.78
Price/Book (mrq)
0.73
Enterprise Value/Revenue
1.18
Enterprise Value/EBITDA
2.73
Financial Highlights
Profitability and Income Statement
Profit Margin
15.74%
Return on Assets (ttm)
1.51%
Return on Equity (ttm)
12.45%
Revenue (ttm)
24.97M
Net Income Avi to Common (ttm)
3.93M
Diluted EPS (ttm)
0.6100
Balance Sheet and Cash Flow
Total Cash (mrq)
13.83M
Total Debt/Equity (mrq)
64.75%
Levered Free Cash Flow (ttm)
-1.03M